Optimus Healthcare Services, Inc. (OHCS) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Optimus Healthcare Services, Inc. (OHCS) trades at $0.0005. Optimus Healthcare Services, Inc. operates in the financial services sector, providing infrastructure and support to community-based oncology practices for clinical trial enrollment. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for OHCS: OHCS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OHCS against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
OHCS: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Optimus Healthcare Services, Inc. (OHCS) Financial Services Profile
Optimus Healthcare Services, Inc. facilitates clinical trial enrollment for oncology practices and offers telehealth solutions for chronic care. Operating within the financial services sector as a shell company, it focuses on infrastructure support and technology platforms, distinguishing itself through specialized services for clinical trials and chronic disease management.
What Is the Investment Thesis for OHCS?
Optimus Healthcare Services, Inc. presents a unique investment proposition due to its focus on supporting community-based oncology practices and its telehealth platform for chronic care management. The company's gross margin of 81.0% indicates strong pricing power within its niche. However, the company's negative profit margin of -741.1% raises concerns about its operational efficiency and cost management. The company's beta of -0.37 suggests a low correlation with the broader market. Key growth catalysts include expanding its telehealth platform and securing additional clinical trial contracts. Investors should closely monitor the company's ability to improve profitability and manage its expenses effectively.
Based on FMP financials and quantitative analysis
OHCS Key Highlights
Optimus Healthcare Services, Inc. operates with a small team of 12 employees, indicating a lean operational structure.
- The company's gross margin stands at 81.0%, reflecting strong pricing power in its specialized services.
- Optimus Healthcare Services, Inc. has a negative profit margin of -741.1%, highlighting significant challenges in achieving profitability.
- The company's beta is -0.37, suggesting a low correlation with the overall market.
- Optimus Healthcare Services, Inc. focuses on providing infrastructure and support for community-based oncology practices in clinical trials.
Who Are OHCS's Competitors?
OHCS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| RCLFU Rosecliff Acquisition Corp I | $11.33 | +11.74% | $77.2M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OHCS's Key Strengths?
Specialized services in clinical trial support for oncology practices.
- Telehealth platform addressing chronic care and substance use disorders.
- Established relationships with pharmaceutical companies and CROs.
- High gross margin of 81.0%.
What Are OHCS's Weaknesses?
Negative profit margin of -741.1%, indicating significant profitability challenges.
- Small number of employees (12), potentially limiting scalability.
- Reliance on a niche market, making it vulnerable to changes in the healthcare industry.
- Limited financial resources compared to larger competitors.
What Could Drive OHCS Stock Higher?
Expansion of telehealth platform to new patient populations.
- Securing additional clinical trial contracts with pharmaceutical companies.
- Strategic partnerships with healthcare providers and technology companies.
What Are the Key Risks for OHCS?
Negative profit margin of -741.1% indicates financial instability.
- Competition from larger and more established companies.
- Changes in healthcare regulations and reimbursement policies.
- Limited liquidity due to OTC listing.
What Are the Growth Opportunities for OHCS?
- Expansion of Telehealth Platform: Optimus Healthcare Services, Inc. can expand its telehealth platform to reach a broader patient base and offer additional services. The telehealth market is projected to reach $555.9 billion by 2033, growing at a CAGR of 22.5% from 2023 to 2033. By enhancing its platform with new features and targeting specific patient populations, the company can capitalize on this growing market and increase its revenue streams. Timeline: Ongoing.
- Securing Additional Clinical Trial Contracts: The company can focus on securing additional contracts with pharmaceutical companies and CROs to conduct clinical trials. The global clinical trials market is expected to reach $69.7 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030. By leveraging its expertise in clinical trial support, Optimus Healthcare Services, Inc. can increase its market share and drive revenue growth. Timeline: Ongoing.
- Strategic Partnerships: Optimus Healthcare Services, Inc. can form strategic partnerships with other healthcare providers and technology companies to expand its reach and enhance its service offerings. Collaborating with established players in the healthcare industry can provide access to new markets and customers, while partnering with technology companies can improve the functionality and user experience of its telehealth platform. Timeline: Ongoing.
- Geographic Expansion: The company can expand its operations to new geographic markets, both domestically and internationally. By targeting regions with high demand for clinical trial support and telehealth services, Optimus Healthcare Services, Inc. can diversify its revenue streams and reduce its reliance on its existing markets. Timeline: 1-3 years.
- Development of New Technologies: Optimus Healthcare Services, Inc. can invest in the development of new technologies to enhance its clinical trial support and telehealth services. This could include developing AI-powered tools for patient recruitment and data analysis, as well as creating new telehealth applications for specific medical conditions. By staying at the forefront of technological innovation, the company can maintain a competitive advantage and attract new customers. Timeline: 2-5 years.
What Threats Does OHCS Face?
- Competition from larger and more established companies in the clinical trial and telehealth markets.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns that could reduce funding for clinical trials and telehealth services.
- Technological advancements that could disrupt the company's business model.
What Are OHCS's Competitive Advantages?
- Specialized expertise in clinical trial support for community-based oncology practices.
- Proprietary telehealth and compliance technology platform tailored for chronic care management.
- Established relationships with pharmaceutical companies and contract research organizations (CROs).
- Focus on a niche market with specific needs and challenges.
What Does OHCS Do?
Optimus Healthcare Services, Inc., based in Westbury, New York, operates within the financial services sector as a shell company. Through its subsidiaries, the company provides community-based oncology practices with the necessary infrastructure and support to enroll their patients in clinical trials. This involves contracting with pharmaceutical companies and contract research organizations (CROs) to conduct clinical trials, spanning Phases I through IV, for investigational new drugs, biologics, and medical devices. In addition to its clinical trial support services, Optimus Healthcare Services, Inc. operates a telehealth and compliance technology software-as-a-service (SaaS) platform. This platform is designed to create personalized pathways to support interventions for chronic care patients, particularly those suffering from opioid and other substance use disorders, as well as patients undergoing pain management. The company's dual focus on clinical trial support and telehealth solutions positions it at the intersection of healthcare and technology, aiming to improve patient outcomes and streamline clinical research processes.
What Products and Services Does OHCS Offer?
- Provides infrastructure and support to community-based oncology practices.
- Facilitates patient enrollment in clinical trials.
- Contracts with pharmaceutical companies and contract research organizations (CROs).
- Conducts clinical trials (Phases I-IV) for investigational new drugs, biologics, and medical devices.
- Operates a telehealth and compliance technology software-as-a-service (SaaS) platform.
- Creates personalized pathways to support interventions for chronic care patients.
- Focuses on patients suffering from opioid and other substance use disorders.
- Supports patients treated for pain management.
How Does OHCS Make Money?
- Contracts with pharmaceutical companies and CROs to conduct clinical trials, generating revenue through service fees.
- Offers a telehealth and compliance technology platform, generating revenue through software-as-a-service (SaaS) subscriptions.
- Provides infrastructure and support services to community-based oncology practices, earning revenue through service agreements.
What Industry Does OHCS Operate In?
Optimus Healthcare Services, Inc. operates within the shell companies industry, which is a subset of the broader financial services sector. The company's focus on providing infrastructure and support for clinical trials aligns with the growing demand for efficient and accessible clinical research solutions. The telehealth market is also experiencing significant growth, driven by increasing adoption of remote healthcare services. Optimus Healthcare Services, Inc. faces competition from other companies offering clinical trial support and telehealth solutions, including AMLH, AWWI, CGSI, ECDD, and IFAN.
Who Are OHCS's Key Customers?
- Community-based oncology practices seeking support for clinical trial enrollment.
- Pharmaceutical companies and contract research organizations (CROs) requiring clinical trial services.
- Chronic care patients, particularly those suffering from opioid and other substance use disorders.
- Patients undergoing pain management.
Financial Health
Optimus Healthcare Services, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
Key Financial Metrics
Return on equity for Optimus Healthcare Services, Inc. stands at 252.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.10 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Optimus Healthcare Services, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Westbury, US. The company is led by CEO Clifford R. Saffron. OHCS has traded publicly since 2002.
OHCS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized services in clinical trial support for oncology practices.
- Telehealth platform addressing chronic care and substance use disorders.
- Established relationships with pharmaceutical companies and CROs.
- High gross margin of 81.0%.
Bear Case
- Negative profit margin of -741.1%, indicating significant profitability challenges.
- Small number of employees (12), potentially limiting scalability.
- Reliance on a niche market, making it vulnerable to changes in the healthcare industry.
- Limited financial resources compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
OHCS Latest News
No recent news available for OHCS.
OHCS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OHCS.
Price Targets
Wall Street price target analysis for OHCS.
OHCS MoonshotScore
What does this score mean?
The MoonshotScore rates OHCS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Clifford R. Saffron
CEO
Clifford R. Saffron serves as the CEO of Optimus Healthcare Services, Inc. His background includes experience in managing small teams and navigating the complexities of the financial services sector, particularly as it relates to shell companies. His leadership is focused on guiding the company's strategic direction and overseeing its operations in the clinical trial support and telehealth markets. He is responsible for managing the company's relationships with pharmaceutical companies, CROs, and community-based oncology practices.
Track Record: Under Clifford R. Saffron's leadership, Optimus Healthcare Services, Inc. has focused on providing infrastructure and support for community-based oncology practices and developing its telehealth platform. Key milestones include securing contracts for clinical trials and expanding the reach of its telehealth services. However, the company's negative profit margin remains a significant challenge. He manages 12 employees.
OHCS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Optimus Healthcare Services, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity may be less frequent compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited transparency and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for wide bid-ask spreads.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company provides clinical trial support and telehealth services.
- Company has a gross margin of 81.0%.
- Company is based in Westbury, New York.
Optimus Healthcare Services, Inc. Financial Services Stock: Key Questions Answered
What does Optimus Healthcare Services, Inc. do?
Optimus Healthcare Services, Inc. operates as a shell company providing essential infrastructure and support to community-based oncology practices, enabling them to enroll patients in clinical trials. The company contracts with pharmaceutical firms and contract research organizations (CROs) to facilitate Phases I-IV clinical trials for new drugs, biologics, and medical devices.
What do analysts say about OHCS stock?
Currently, there is no available analyst coverage or consensus on Optimus Healthcare Services, Inc. (OHCS) due to its OTC listing and limited market capitalization. Investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC stocks, including limited liquidity and financial disclosure.
What are the main risks for OHCS?
Optimus Healthcare Services, Inc. faces several key risks. Its negative profit margin of -741.1% indicates significant financial challenges. As an OTC-listed company, it faces liquidity risks and limited regulatory oversight. Competition from larger, more established companies in the clinical trial and telehealth markets poses a threat. Changes in healthcare regulations and reimbursement policies could also negatively impact its business model. Investors should carefully consider these risks before investing in OHCS.
How does Optimus Healthcare Services, Inc. make money in financial services?
Optimus Healthcare Services, Inc. generates revenue primarily through two streams: clinical trial support services and its telehealth platform. For clinical trials, the company contracts with pharmaceutical companies and contract research organizations (CROs) to conduct various phases of clinical trials, earning fees for its infrastructure and support services.
What is Optimus Healthcare Services, Inc.'s credit quality and risk management approach?
Due to the limited information available on Optimus Healthcare Services, Inc., particularly its OTC listing and lack of analyst coverage, assessing its credit quality and risk management approach is challenging. The company's negative profit margin of -741.1% raises concerns about its financial stability.
What are the key factors to evaluate for OHCS?
Evaluate OHCS on fundamentals, analyst consensus, and risk factors. Optimus Healthcare Services, Inc. presents a unique investment proposition due to its focus on supporting community-based oncology practices and its telehealth platform for chronic care management. Not financial advice.
How frequently does OHCS data refresh on this page?
OHCS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven OHCS's recent stock price performance?
Optimus Healthcare Services, Inc. (OHCS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized services in clinical trial support for oncology practices. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing and lack of analyst coverage.
- Financial data based on available information and may not be comprehensive.